Latest News

narcolepsy sleep disorders
Positive Data Presentation on Oveporexton for Narcolepsy

September 10th 2025

Takeda's oveporexton shows promising results in treating narcolepsy type 1, significantly improving symptoms and quality of life in clinical trials.

sleeo brain
Alixorexton for Narcolepsy Type 1: New Detailed Positive Phase 2 Results From Vibrance-1 Study

September 9th 2025

narcolepsy
Optimizing Narcolepsy Management: A Clinical Update

August 18th 2025

sleep eating disorder
Sleep-Related Eating Disorder: A Distressing But Treatable Complex Parasomnia

August 13th 2025

sleep
Positive Topline Results From Phase 3 Trial of AD109, First Oral Pill for Obstructive Sleep Apnea

July 23rd 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.